| Dr Jesse E Morriss Iii, MD | |
|
1901 Melba Dr, Dothan, AL 36301-3017 | |
| (334) 794-6611 | |
| (334) 794-6614 |
| Full Name | Dr Jesse E Morriss Iii |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 42 Years |
| Location | 1901 Melba Dr, Dothan, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063481273 | NPI | - | NPPES |
| 00014487 | Medicaid | AL | |
| 051014487 | Other | AL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 00011982 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gentiva Hospice - Dothan | Dothan, AL | Hospice |
| Southeast Alabama Medical Center | Dothan, AL | Hospital |
| Flowers Hospital | Dothan, AL | Hospital |
| Wesley Place On Honeysuckle | Dothan, AL | Nursing home |
| Extendicare Health Center | Dothan, AL | Nursing home |
| Westside Terrace Health & Rehabilitation Center | Dothan, AL | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Clinic Pc | 1355329269 | 19 |
News Archive
Preliminary research suggests that criteria based on computed tomography (CT) imaging of changes in tumors from colorectal liver metastases after chemotherapy with the drug bevacizumab may have the potential to predict overall survival, according to a study in the December 2 issue of JAMA.
The presence of circulating tumor DNA (ctDNA) isolated from blood samples of patients with pancreatic adenocarcinoma was associated with poor outcomes.
An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.
"Vancouver's Insite clinic, the only such safe-injection site for people who use drugs in North America, can stay open, the Supreme Court of Canada ruled on Friday in a landmark defeat for the federal government," Reuters reports.
› Verified 8 days ago
| Entity Name | Southern Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053410480 PECOS PAC ID: 1355329269 Enrollment ID: O20040708000585 |
News Archive
Preliminary research suggests that criteria based on computed tomography (CT) imaging of changes in tumors from colorectal liver metastases after chemotherapy with the drug bevacizumab may have the potential to predict overall survival, according to a study in the December 2 issue of JAMA.
The presence of circulating tumor DNA (ctDNA) isolated from blood samples of patients with pancreatic adenocarcinoma was associated with poor outcomes.
An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.
"Vancouver's Insite clinic, the only such safe-injection site for people who use drugs in North America, can stay open, the Supreme Court of Canada ruled on Friday in a landmark defeat for the federal government," Reuters reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jesse E Morriss Iii, MD 1901 Melba Dr, Dothan, AL 36301-3017 Ph: (334) 794-6611 | Dr Jesse E Morriss Iii, MD 1901 Melba Dr, Dothan, AL 36301-3017 Ph: (334) 794-6611 |
News Archive
Preliminary research suggests that criteria based on computed tomography (CT) imaging of changes in tumors from colorectal liver metastases after chemotherapy with the drug bevacizumab may have the potential to predict overall survival, according to a study in the December 2 issue of JAMA.
The presence of circulating tumor DNA (ctDNA) isolated from blood samples of patients with pancreatic adenocarcinoma was associated with poor outcomes.
An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.
"Vancouver's Insite clinic, the only such safe-injection site for people who use drugs in North America, can stay open, the Supreme Court of Canada ruled on Friday in a landmark defeat for the federal government," Reuters reports.
› Verified 8 days ago
Parks Winfield Pratt Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St, Suite 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-671-8907 | |
Mr. Rodney K Beauchamp, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Parkwest Cir Ste 2, Dothan, AL 36303 Phone: 334-699-2004 | |
Brian Reynolds Sinclair, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1450 Ross Clark Cir Ste 400, Dothan, AL 36301 Phone: 334-305-0400 Fax: 334-305-0401 | |
Dr. Olawale Mayokun Osunsanya, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1763 E Main St, Dothan, AL 36301 Phone: 334-793-3319 Fax: 334-793-2291 | |
Jeffrey John Crittenden, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 480 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-836-1212 Fax: 334-836-1888 | |
Dr. Venkat R Nimmagadda, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1540 E Main St, Dothan, AL 36301 Phone: 334-793-2618 Fax: 334-792-7353 | |
Christopher O. Ike, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St Ste 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-340-2805 |